Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial

Autor: Henrik Vase, Anna E. Oczachowska-Kulik, Ingrid M. Thomsen, Erling B. Pedersen, Thomas Larsen, Bartlomiej Jonczy, Frank H Mose, Annebirthe B. Hansen, Renata Kosierkiewic, Anne Sp P. Kancir, Jesper N. Bech

Publikováno v: BMC Nephrology
Mose, F H, Vase, H, Larsen, T, Kancir, A S P, Kosierkiewic, R, Jonczy, B, Hansen, A B, Oczachowska-Kulik, A E, Thomsen, I M, Bech, J N & Pedersen, E B 2014, ' Cardiovascular effects of cholecalciferol treatment in dialysis patients : a randomized controlled trial ', B M C Nephrology, vol. 15, 50 . https://doi.org/10.1186/1471-2369-15-50

Patients on chronic dialysis are at increased risk of vitamin D deficiency. In observational studies plasma 25-hydroxyvitamin D (p-25(OH) D) levels are inversely correlated with plasma BNP and adverse cardiovascular outcomes. Whether a causal relatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb2588f139982b156372dfbd03d39cf9